Delivery Order SPE2DE24D0013-SPE2D625F2KEB
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $10.2K firm fixed-price delivery order to Cepheid Inc. on July 22, 2025, for the XpertXpress COVID-19, Influenza, RSV, and Molecular Biology test kit. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will perform the work at its California facility. This delivery order carries no set-aside designation and represents a continuation of Cepheid's long-standing relationship supplying diagnostic...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The Defense Logistics Agency's Medical Supply Chain awarded a $6.8K firm fixed-price delivery order to Cepheid for the provision of COVID-19/Influenza/RSV diagnostic test kits (10-test viral test kits). The contract, awarded on July 25, 2025, with an ultimate completion date of July 30, 2025, carries no set-aside designation. Performance of this delivery order will occur at Cepheid's facility in Sunnyvale, California. This award represents a discrete procurement action under the federal...
- The Defense Department's Medical Supply Chain awarded Cepheid a $6.8K firm fixed-price delivery order on August 14, 2025, for the XpertXpress COVID-19, Flu, RSV, and molecular biology test kit. This delivery order represents a single procurement action under one of Cepheid's larger indefinite delivery vehicles with the Department of Veterans Affairs (VA), which provides ongoing access to the company's molecular diagnostic testing systems and reagents. The contract is set to complete by August...
- The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $14,448 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and will be performed at Cepheid's...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $13,980 to Cepheid Inc. for COVID-19/Influenza/RSV diagnostic test kits on August 8, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents procurement of molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer. The delivery order will be performed at Cepheid's Sunnyvale facility. This...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, on September 10, 2025. The delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, carries no set-aside designation. This award represents a procurement of diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2KEBDelivery Order
The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. for the supply of XPert Xpress COVID-19, Influenza, and RSV molecular diagnostic test kits. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 10, 2025, represents a routine procurement under Cepheid's existing federal contract vehicles. The work will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and reflects standard procurement practices for infectious disease diagnostic solutions within the federal healthcare supply chain. Cepheid, a leading manufacturer of molecular diagnostic systems and reagents, has established itself as a key supplier to multiple federal agencies, including the Department of Veterans Affairs and the Defense Health Agency. The company maintains significant indefinite delivery vehicle contracts with VA networks valued at over $35 million, enabling continuous procurement of PCR-based diagnostic testing solutions for conditions including COVID-19, influenza, RSV, and other infectious diseases. This delivery order for diagnostic test kits aligns with Cepheid's core competencies in point-of-care molecular diagnostics and supports the federal government's ongoing capability to conduct rapid infectious disease testing across military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/3/25 |